BiotechTube

E2/DRSP (BAY 86-4891) dose 1 (SH T04984E) + E2/DRSP (BAY 86-4891) dose 2 (80458739) + E2/DRSP (BAY 86-4891) dose 3 (80458755) + E2/DRSP (BAY 86-4891) dose 4 (80458720) + E2/DRSP (BAY 86-4891) dose 5 (80458712) + DRSP (ZK 30595) dose 1 (SH T04984F) + DRSP (ZK 30595) dose 2 (80458690) + Placebo

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Contraceptive, Oral, Hormonal

Conditions

Contraceptive, Oral, Hormonal

Trial Timeline

Mar 1, 2008 → Jun 1, 2009

NCT ID
NCT00653614

About E2/DRSP (BAY 86-4891) dose 1 (SH T04984E) + E2/DRSP (BAY 86-4891) dose 2 (80458739) + E2/DRSP (BAY 86-4891) dose 3 (80458755) + E2/DRSP (BAY 86-4891) dose 4 (80458720) + E2/DRSP (BAY 86-4891) dose 5 (80458712) + DRSP (ZK 30595) dose 1 (SH T04984F) + DRSP (ZK 30595) dose 2 (80458690) + Placebo

E2/DRSP (BAY 86-4891) dose 1 (SH T04984E) + E2/DRSP (BAY 86-4891) dose 2 (80458739) + E2/DRSP (BAY 86-4891) dose 3 (80458755) + E2/DRSP (BAY 86-4891) dose 4 (80458720) + E2/DRSP (BAY 86-4891) dose 5 (80458712) + DRSP (ZK 30595) dose 1 (SH T04984F) + DRSP (ZK 30595) dose 2 (80458690) + Placebo is a phase 2 stage product being developed by Bayer for Contraceptive, Oral, Hormonal. The current trial status is completed. This product is registered under clinical trial identifier NCT00653614. Target conditions include Contraceptive, Oral, Hormonal.

What happened to similar drugs?

0 of 5 similar drugs in Contraceptive, Oral, Hormonal were approved

Approved (0) Terminated (0) Active (5)
🔄Levonorgestrel 90 mg and Ethinyl Estradiol 20 mgPfizerPhase 3
🔄EE20/DRSP (YAZ, BAY86-5300) + Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)BayerPhase 3
🔄EV/DNG (Qlaira, BAY86-5027) + Encapsulated Microgynon + PlaceboBayerPhase 3
🔄Valette (Dienogest/EE30, BAY86-5038) + Valette (Dienogest/EE30, BAY86-5038)BayerPhase 3
🔄Etonogestrel contraceptive implantBayerPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00653614Phase 2Completed

Competing Products

13 competing products in Contraceptive, Oral, Hormonal

See all competitors
ProductCompanyStageHype Score
AZD1981 + Neovletta 21/28 + Placebo AZD1981AstraZenecaPhase 1
29
fostamatinib + Microgynon® 30 (Oral contraceptive) + PlaceboAstraZenecaPhase 1
29
Leios/AlessePfizerPre-clinical
26
Levonorgestrel 90 mg and Ethinyl Estradiol 20 mgPfizerPhase 3
40
EE20/DRSP (YAZ, BAY86-5300) + Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)BayerPhase 3
37
EV/DNG (Qlaira, BAY86-5027) + Encapsulated Microgynon + PlaceboBayerPhase 3
37
SH T04769G + Ethinyl estradiol / dienogest (SH D00659 AF)BayerPhase 2
32
Valette (Dienogest/EE30, BAY86-5038) + Valette (Dienogest/EE30, BAY86-5038)BayerPhase 3
37
EV/DNG (Qlaira, BAY86-5027) + Progestin Only PillsBayerPre-clinical
23
Norethisterone enantate/estradiol valerate (Mesigyna, BAY98-7040)BayerPre-clinical
23
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) + Yasminelle (SH T 00186 D)BayerPhase 2
32
Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2BayerPhase 1
26
Etonogestrel contraceptive implantBayerPhase 3
37